Inflammatory Bowel Diseases 1986, Softcover reprint of the original 1st ed. 1986 Proceedings of the Second International Symposium on Inflammatory Bowel Diseases, Jerusalem, September 8–11, 1985 Developments in Gastroenterology Series, Vol. 8

The Second International Symposium on Inflammatory Bowel Diseases was held in Jerusalem from September 8-11, 1985, under the auspices of the Israel Academy of Sciences, the Israel Gastroenterological Society and the Hebrew University-Hadassah Medical School. Five hundred physicians and researchers from 26 countries attended. The symposium was organized into six panels devoted to state of the art reviews and presentations of the latest findings and approaches on etiology, pathogenesis, medical and surgical management of IBD and clini­ cal assessment of disease. In addition, 89 abstracts were presented as posters during the symposium, all of which were published in the book of abstracts. The concluding panel outlined new directions for future re­ search on IBD. The organizing committee gratefully acknowledges all the contributors who presented their work in a clear and concise manner, and to all the participants whose active role in the discussions contributed to the suc­ cess of the meeting. In view of the great interest in the symposium and the tradition es­ tablished following the first, in 1981, it was decided to convene a third international symposium on IBD in Jerusalem in September 1989.

Session 1: Etiology.- Attempts to identify a viral etiology for inflammatory bowel diseases (IBD).- Bacterial etiology of inflammatory disease.- Study of a new Mycobacterium isolated from patients with Crohn’s disease.- Etiopathogenesis of inflammatory bowel disease.- Animal model of granulomatous entrocolitis induced by bacterial cell wall polymers.- Session 2: Pathogenesis.- Epidemiology of inflammatory bowel disease – 1985.- Intestinal mucosal lymphocytes: a new approach to the pathogenesis of inflammatory bowel.- Role of interferon in the pathogenesis of inflammatory bowel disease.- Role of lipoxygenase products as mediators of inflammation in IBD.- Session 3: Clinical Assessment of Disease.- Inflammatory bowel disease – aspects of differential diagnosis.- Quantifying ‘activity’ of inflammatory bowel disease.- Diagnosis of dysplasia in ulcerative colitis by combined light microscopy and scanning electron microscopy.- Psychiatric evaluation in inflammatory bowel disease – practical considerations.- Prognostic factors for recurrence of Crohn’s disease.- Cancer surveillance in ulcerative colitis.- Surveillance of patients with ulcerative colitis: an Italian experience.- The social prognosis in inflammatory bowel disease.- Session 4: Medical Management.- Corticosteroids and inflammatory bowel disease.- Metronidazole in Crohn’s disease.- The current role of irnmunosuppresives in the treatment of inflammatory bowel disease.- Hyperalimentation in inflammatory bowel disease: uses and abuses.- New salicylates in treatment of inflammatory bowel disease.- Growth failure in inflammatory bowel disease.- Session 5: Surgical Management.- Surgical management of inflammatory bowel disease.- Long-term results of continent ileostomy.- Ileorectal anastomosis forulcerative colitis.- Continence following soave procedure for ulcerative colitis.- Surgery in Crohn’s disease: limited versus wide resection.- Towards conservative surgery in the management of Crohn’s disease.- Session 6: New Directions for Future Research.- Future directions for clinical research.- New directions for future research.- Future directions for immunological research.- Observations on inflammatory bowel disease – 1985: present status and future prospects.